Literature DB >> 27645239

Nationwide Surveillance of Novel Oxazolidinone Resistance Gene optrA in Enterococcus Isolates in China from 2004 to 2014.

Lanqing Cui1, Yang Wang2, Yuan Lv3, Shan Wang1, Yunjia Song1, Yun Li1, Jian Liu1, Feng Xue1, Weiwei Yang1, Jia Zhang1.   

Abstract

A total of 2,201 nonduplicate enterococcal isolates collected from 29 hospitals in 23 cities in China between 2004 and 2014 were screened for the oxazolidinone resistance gene optrA; 45 isolates (2.0%) were optrA positive with 11 OptrA variants identified. The positive rate of optrA increased from 0.4% to 3.9% during the 10-year surveillance period. Pulsed-field gel electrophoresis (PFGE) and multilocus sequence type (MLST) analysis revealed that 37 optrA-positive Enterococcus faecalis isolates clustered into 25 PFGE patterns and 21 sequence types, while 6 Enterococcus faecium isolates represented 6 PFGE patterns and 6 sequence types. The present study underscores the importance of routine and persistent monitoring of oxazolidinone resistance and optrA gene.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27645239      PMCID： PMC5119033          DOI： 10.1128/AAC.01256-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  14 in total

1.  Use of a genus- and species-specific multiplex PCR for identification of enterococci.

Authors:  Charlene R Jackson; Paula J Fedorka-Cray; John B Barrett
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

2.  Intensive care unit dissemination of multiple clones of linezolid-resistant Enterococcus faecalis and Enterococcus faecium.

Authors:  Eleni Ntokou; Constantinos Stathopoulos; Ioulia Kristo; Evangelia Dimitroulia; Maria Labrou; Afroditi Vasdeki; Demosthenes Makris; Epameinondas Zakynthinos; Athanassios Tsakris; Spyros Pournaras
Journal:  J Antimicrob Chemother       Date:  2012-04-24       Impact factor: 5.790

3.  Stability of linezolid activity in an era of mobile oxazolidinone resistance determinants: results from the 2009 Zyvox® Annual Appraisal of Potency and Spectrum program.

Authors:  Douglas J Biedenbach; David J Farrell; Rodrigo E Mendes; James E Ross; Ronald N Jones
Journal:  Diagn Microbiol Infect Dis       Date:  2010-12       Impact factor: 2.803

Review 4.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

5.  Surveillance for linezolid resistance via the Zyvox® Annual Appraisal of Potency and Spectrum (ZAAPS) programme (2014): evolving resistance mechanisms with stable susceptibility rates.

Authors:  Rodrigo E Mendes; Patricia A Hogan; Ronald N Jones; Helio S Sader; Robert K Flamm
Journal:  J Antimicrob Chemother       Date:  2016-03-23       Impact factor: 5.790

6.  Detection of the van alphabet and identification of enterococci and staphylococci at the species level by multiplex PCR.

Authors:  Florence Depardieu; Bruno Perichon; Patrice Courvalin
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

Review 7.  Linezolid, the first oxazolidinone antibacterial agent.

Authors:  Karen L Leach; Steven J Brickner; Mark C Noe; Paul F Miller
Journal:  Ann N Y Acad Sci       Date:  2011-03       Impact factor: 5.691

8.  Co-location of the oxazolidinone resistance genes optrA and cfr on a multiresistance plasmid from Staphylococcus sciuri.

Authors:  Dexi Li; Yang Wang; Stefan Schwarz; Jiachang Cai; Run Fan; Jun Li; Andrea T Feßler; Rong Zhang; Congming Wu; Jianzhong Shen
Journal:  J Antimicrob Chemother       Date:  2016-03-06       Impact factor: 5.790

9.  Detection of a New cfr-Like Gene, cfr(B), in Enterococcus faecium Isolates Recovered from Human Specimens in the United States as Part of the SENTRY Antimicrobial Surveillance Program.

Authors:  Lalitagauri M Deshpande; Deborah S Ashcraft; Heather P Kahn; George Pankey; Ronald N Jones; David J Farrell; Rodrigo E Mendes
Journal:  Antimicrob Agents Chemother       Date:  2015-07-27       Impact factor: 5.191

10.  Linezolid Surveillance Results for the United States (LEADER Surveillance Program 2014).

Authors:  Robert K Flamm; Rodrigo E Mendes; Patricia A Hogan; Jennifer M Streit; James E Ross; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191
View more
  18 in total

1.  Five-Year Summary of In Vitro Activity and Resistance Mechanisms of Linezolid against Clinically Important Gram-Positive Cocci in the United States from the LEADER Surveillance Program (2011 to 2015).

Authors:  Michael A Pfaller; Rodrigo E Mendes; Jennifer M Streit; Patricia A Hogan; Robert K Flamm
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

2.  Transferable Resistance Gene optrA in Enterococcus faecalis from Swine in Brazil.

Authors:  Lara M Almeida; François Lebreton; Anthony Gaca; Paulo M Bispo; Jose T Saavedra; Rodrigo N Calumby; Luciano M Grillo; Ticiano G Nascimento; Pedro H Filsner; Andrea M Moreno; Michael S Gilmore
Journal:  Antimicrob Agents Chemother       Date:  2020-05-21       Impact factor: 5.191

3.  Linezolid- and Vancomycin-resistant Enterococcus faecium in Solid Organ Transplant Recipients: Infection Control and Antimicrobial Stewardship Using Whole Genome Sequencing.

Authors:  Lilian Abbo; Bhavarth S Shukla; Amber Giles; Laura Aragon; Adriana Jimenez; Jose F Camargo; Jacques Simkins; Kathleen Sposato; Truc T Tran; Lorena Diaz; Jinnethe Reyes; Rafael Rios; Lina P Carvajal; Javier Cardozo; Maribel Ruiz; Gemma Rosello; Armando Perez Cardona; Octavio Martinez; Giselle Guerra; Thiago Beduschi; Rodrigo Vianna; Cesar A Arias
Journal:  Clin Infect Dis       Date:  2019-07-02       Impact factor: 9.079

4.  Epidemiological characteristics and genetic structure of linezolid-resistant Enterococcus faecalis.

Authors:  Meijuan Chen; Hongying Pan; Yaling Lou; Zhe Wu; Jiajie Zhang; Yicheng Huang; Wei Yu; Yunqing Qiu
Journal:  Infect Drug Resist       Date:  2018-11-20       Impact factor: 4.003

5.  Molecular Epidemiology and Mechanisms of 43 Low-Level Linezolid-Resistant Enterococcus faecalis Strains in Chongqing, China.

Authors:  Ruoyi Hua; Yun Xia; Wenyao Wu; Mi Yang; Jia Yan
Journal:  Ann Lab Med       Date:  2019-01       Impact factor: 3.464

6.  Complete Genome Sequence and Characterization of Linezolid-Resistant Enterococcus faecalis Clinical Isolate KUB3006 Carrying a cfr(B)-Transposon on Its Chromosome and optrA-Plasmid.

Authors:  Makoto Kuroda; Tsuyoshi Sekizuka; Hidehito Matsui; Katsunori Suzuki; Hiroyuki Seki; Mitsumasa Saito; Hideaki Hanaki
Journal:  Front Microbiol       Date:  2018-10-25       Impact factor: 5.640

7.  Mobile Oxazolidinone Resistance Genes in Gram-Positive and Gram-Negative Bacteria.

Authors:  Stefan Schwarz; Wanjiang Zhang; Xiang-Dang Du; Henrike Krüger; Andrea T Feßler; Shizhen Ma; Yao Zhu; Congming Wu; Jianzhong Shen; Yang Wang
Journal:  Clin Microbiol Rev       Date:  2021-06-02       Impact factor: 50.129

8.  Commentary: Nationwide Surveillance of Novel Oxazolidinone Resistance Gene optrA in Enterococcus Isolates in China from 2004 to 2014.

Authors:  Gianluca Morroni; Andrea Brenciani; Serena Simoni; Carla Vignaroli; Marina Mingoia; Eleonora Giovanetti
Journal:  Front Microbiol       Date:  2017-08-24       Impact factor: 5.640

9.  Quantitative Proteomics Analysis of Membrane Proteins in Enterococcus faecalis With Low-Level Linezolid-Resistance.

Authors:  Jia Yan; Yun Xia; Mi Yang; Jiaqi Zou; Yingzhu Chen; Dawei Zhang; Liang Ma
Journal:  Front Microbiol       Date:  2018-07-27       Impact factor: 5.640

10.  Comparative genomics of global optrA-carrying Enterococcus faecalis uncovers a common chromosomal hotspot for optrA acquisition within a diversity of core and accessory genomes.

Authors:  Ana R Freitas; Ana P Tedim; Carla Novais; Val F Lanza; Luísa Peixe
Journal:  Microb Genom       Date:  2020-03-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.